These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

718 related items for PubMed ID: 29792038

  • 1. Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.
    Liu M, Bamodu OA, Kuo KT, Lee WH, Lin YK, Wu ATH, M H, Tzeng YM, Yeh CT, Tsai JT.
    Am J Chin Med; 2018; 46(4):891-910. PubMed ID: 29792038
    [Abstract] [Full Text] [Related]

  • 2. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX, Qi Y, Zhang J, Liu Y, Xu WH, Xu J, Hu HG, Wu QY, Wang Y, Zhang JP.
    Oncotarget; 2016 Nov 29; 7(48):79544-79556. PubMed ID: 27783993
    [Abstract] [Full Text] [Related]

  • 3. miR-217 targeting DKK1 promotes cancer stem cell properties via activation of the Wnt signaling pathway in hepatocellular carcinoma.
    Jiang C, Yu M, Xie X, Huang G, Peng Y, Ren D, Lin M, Liu B, Liu M, Wang W, Kuang M.
    Oncol Rep; 2017 Oct 29; 38(4):2351-2359. PubMed ID: 28849121
    [Abstract] [Full Text] [Related]

  • 4. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L, Wang X, Jia T, Wei W, Chua MS, So S.
    Oncotarget; 2015 Sep 22; 6(28):25390-401. PubMed ID: 26246473
    [Abstract] [Full Text] [Related]

  • 5. Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment.
    Vilchez V, Turcios L, Marti F, Gedaly R.
    World J Gastroenterol; 2016 Jan 14; 22(2):823-32. PubMed ID: 26811628
    [Abstract] [Full Text] [Related]

  • 6. Targeting the Epigenetic Non-Coding RNA MALAT1/Wnt Signaling Axis as a Therapeutic Approach to Suppress Stemness and Metastasis in Hepatocellular Carcinoma.
    Chang HL, Bamodu OA, Ong JR, Lee WH, Yeh CT, Tsai JT.
    Cells; 2020 Apr 20; 9(4):. PubMed ID: 32326045
    [Abstract] [Full Text] [Related]

  • 7. GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes.
    Feng H, Zhu M, Zhang R, Wang Q, Li W, Dong X, Chen Y, Lu Y, Liu K, Lin B, Guo J, Li M.
    J Cell Mol Med; 2019 Apr 20; 23(4):2536-2548. PubMed ID: 30672133
    [Abstract] [Full Text] [Related]

  • 8. 6-C-(E-Phenylethenyl)Naringenin Attenuates the Stemness of Hepatocellular Carcinoma Cells by Suppressing Wnt/β-Catenin Signaling.
    Kang Q, Gong J, Wang M, Wang Q, Chen F, Cheng KW.
    J Agric Food Chem; 2019 Dec 18; 67(50):13939-13947. PubMed ID: 31769973
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-452 promotes stem-like cells of hepatocellular carcinoma by inhibiting Sox7 involving Wnt/β-catenin signaling pathway.
    Zheng Z, Liu J, Yang Z, Wu L, Xie H, Jiang C, Lin B, Chen T, Xing C, Liu Z, Song P, Yin S, Zheng S, Zhou L.
    Oncotarget; 2016 May 10; 7(19):28000-12. PubMed ID: 27058905
    [Abstract] [Full Text] [Related]

  • 10. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
    Li B, Cao Y, Meng G, Qian L, Xu T, Yan C, Luo O, Wang S, Wei J, Ding Y, Yu D.
    EBioMedicine; 2019 Jan 10; 39():239-254. PubMed ID: 30555042
    [Abstract] [Full Text] [Related]

  • 11. COLEC10 inhibits the stemness of hepatocellular carcinoma by suppressing the activity of β-catenin signaling.
    Cai MN, Chen DM, Chen XR, Gu YR, Liao CH, Xiao LX, Wang JL, Lin BL, Huang YH, Lian YF.
    Cell Oncol (Dordr); 2024 Oct 10; 47(5):1897-1910. PubMed ID: 39080215
    [Abstract] [Full Text] [Related]

  • 12. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
    Lee SH, Koo BS, Kim JM, Huang S, Rho YS, Bae WJ, Kang HJ, Kim YS, Moon JH, Lim YC.
    J Pathol; 2014 Sep 10; 234(1):99-107. PubMed ID: 24871033
    [Abstract] [Full Text] [Related]

  • 13. CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment.
    Kim JY, Lee HY, Park KK, Choi YK, Nam JS, Hong IS.
    Oncotarget; 2016 Apr 12; 7(15):20395-409. PubMed ID: 26967248
    [Abstract] [Full Text] [Related]

  • 14. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y, Jiang L, Hu Y, Xiao C, Xu N, Zhou J, Zhou X.
    BMC Cancer; 2017 Feb 28; 17(1):161. PubMed ID: 28241806
    [Abstract] [Full Text] [Related]

  • 15. Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma.
    Pandit H, Li Y, Li X, Zhang W, Li S, Martin RCG.
    BMC Cancer; 2018 Aug 03; 18(1):783. PubMed ID: 30075764
    [Abstract] [Full Text] [Related]

  • 16. PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation.
    Liu Y, Ye X, Zhang JB, Ouyang H, Shen Z, Wu Y, Wang W, Wu J, Tao S, Yang X, Qiao K, Zhang J, Liu J, Fu Q, Xie Y.
    Oncogene; 2015 Oct 29; 34(44):5524-35. PubMed ID: 25684142
    [Abstract] [Full Text] [Related]

  • 17. Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.
    Jiang N, Chen WJ, Zhang JW, Xu C, Zeng XC, Zhang T, Li Y, Wang GY.
    Oncotarget; 2015 Apr 10; 6(10):7866-79. PubMed ID: 25797263
    [Abstract] [Full Text] [Related]

  • 18. Chitosan promotes cancer progression and stem cell properties in association with Wnt signaling in colon and hepatocellular carcinoma cells.
    Chang PH, Sekine K, Chao HM, Hsu SH, Chern E.
    Sci Rep; 2017 Apr 03; 8():45751. PubMed ID: 28367998
    [Abstract] [Full Text] [Related]

  • 19. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
    Wang R, Sun Q, Wang P, Liu M, Xiong S, Luo J, Huang H, Du Q, Geller DA, Cheng B.
    Oncotarget; 2016 Feb 02; 7(5):5754-68. PubMed ID: 26735577
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma.
    Zeng XC, Liu FQ, Yan R, Yi HM, Zhang T, Wang GY, Li Y, Jiang N.
    Mol Cancer; 2014 Dec 10; 13():261. PubMed ID: 25491321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.